SG10201506652QA - Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside - Google Patents

Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside

Info

Publication number
SG10201506652QA
SG10201506652QA SG10201506652QA SG10201506652QA SG10201506652QA SG 10201506652Q A SG10201506652Q A SG 10201506652QA SG 10201506652Q A SG10201506652Q A SG 10201506652QA SG 10201506652Q A SG10201506652Q A SG 10201506652QA SG 10201506652Q A SG10201506652Q A SG 10201506652QA
Authority
SG
Singapore
Prior art keywords
nucleoside
hcv
combination
macrocyclic inhibitor
macrocyclic
Prior art date
Application number
SG10201506652QA
Other languages
English (en)
Inventor
Tse-I Lin
Oliver Lenz
Pierre Jean-Marie Bernard Raboisson
Original Assignee
Janssen Pharmaceuticals Inc
Medivir Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceuticals Inc, Medivir Ab filed Critical Janssen Pharmaceuticals Inc
Publication of SG10201506652QA publication Critical patent/SG10201506652QA/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SG10201506652QA 2010-04-13 2011-04-13 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside SG10201506652QA (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP10159825 2010-04-13

Publications (1)

Publication Number Publication Date
SG10201506652QA true SG10201506652QA (en) 2015-10-29

Family

ID=42237337

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201506652QA SG10201506652QA (en) 2010-04-13 2011-04-13 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside
SG2012075057A SG184524A1 (en) 2010-04-13 2011-04-13 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside

Family Applications After (1)

Application Number Title Priority Date Filing Date
SG2012075057A SG184524A1 (en) 2010-04-13 2011-04-13 Combination of a macrocyclic inhibitor of hcv, a non-nucleoside and a nucleoside

Country Status (14)

Country Link
US (1) US20130028865A1 (pt)
EP (1) EP2558091A1 (pt)
JP (1) JP5989635B2 (pt)
KR (1) KR20130057990A (pt)
CN (1) CN102844028B (pt)
AU (1) AU2011239974B2 (pt)
BR (1) BR112012026016A2 (pt)
CA (1) CA2796243A1 (pt)
EA (1) EA201291042A1 (pt)
HK (1) HK1180222A1 (pt)
MX (1) MX2012011963A (pt)
NZ (1) NZ602552A (pt)
SG (2) SG10201506652QA (pt)
WO (1) WO2011128378A1 (pt)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PE20070211A1 (es) 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
TWI454476B (zh) 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
CN104780921A (zh) * 2012-08-31 2015-07-15 杨森制药公司 Hcv的大环蛋白酶抑制剂、非核苷hcv抑制剂和利托那韦的组合

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2552319C (en) 2004-01-30 2012-08-21 Medivir Ab Hcv ns-3 serine protease inhibitors
PE20070211A1 (es) * 2005-07-29 2007-05-12 Medivir Ab Compuestos macrociclicos como inhibidores del virus de hepatitis c
KR20090078347A (ko) 2006-10-10 2009-07-17 메디비르 아베 Ｈｃｖ 뉴클레오시드 억제제
TWI454476B (zh) * 2008-07-08 2014-10-01 Tibotec Pharm Ltd 用作ｃ型肝炎病毒抑制劑之巨環吲哚衍生物
TW201023858A (en) * 2008-09-18 2010-07-01 Ortho Mcneil Janssen Pharm Synergistic combinations of a macrocyclic inhibitor of HCV and a nucleoside
AR077125A1 (es) * 2009-06-23 2011-08-03 Gilead Sciences Inc Combinaciones farmaceuticas utiles para tratar el vhc

Also Published As

Publication number Publication date
MX2012011963A (es) 2012-12-17
JP2013523866A (ja) 2013-06-17
NZ602552A (en) 2014-09-26
CA2796243A1 (en) 2011-10-20
US20130028865A1 (en) 2013-01-31
EP2558091A1 (en) 2013-02-20
KR20130057990A (ko) 2013-06-03
AU2011239974A1 (en) 2012-10-25
AU2011239974B2 (en) 2015-12-03
JP5989635B2 (ja) 2016-09-07
EA201291042A1 (ru) 2013-03-29
SG184524A1 (en) 2012-11-29
WO2011128378A1 (en) 2011-10-20
CN102844028B (zh) 2016-04-06
HK1180222A1 (zh) 2013-10-18
CN102844028A (zh) 2012-12-26
BR112012026016A2 (pt) 2016-06-07

Similar Documents

Publication Publication Date Title
HUS1900021I1 (hu) Nem nukleozid reverz transzkriptáz inhibitorok
HK1191000A1 (en) Macrocyclic inhibitors of flaviviridae viruses
HK1177937A1 (en) Crystalline forms of a macrolide, and uses therefor
GB201012175D0 (en) Procedure and mechanisms
ZA201109034B (en) Aminopyrrolidinone derivatives and uses thereof
EP2410125A4 (en) GAS TURBINE
GB2491791B (en) Gas turbines
EP2625073A4 (en) GAS GENERATOR
HK1169699A1 (en) Gas burner
EP2393836A4 (en) SAM-6 VARIANTS, TARGET AND USE PROCESS
EP2522830A4 (en) GAS TURBINE
EP2490541A4 (en) 2-SUBSTITUTED ETHYL HYLTHIAZONE DERIVATIVES AND THEIR USE
PL2655966T3 (pl) Palnik gazowy
HK1180726A1 (en) Kras primers and probes kras
HK1180222A1 (zh) 大環抑制劑、非核苷和核苷的組合
GB201020418D0 (en) Fluid impingement arrangement
IL237049A0 (en) Combination of HCV macrocyclic tertase inhibitor, non-nucleoside HCV inhibitor and ritonavir
HK1152454A2 (en) Gas stove
GB201016581D0 (en) Gas firepit burner
HK1221229A1 (zh) 大環內酯的晶形及其用途
GB201022063D0 (en) Magic glow key
GB2479614B (en) Gas fires
AU332999S (en) Gas cookers
PL390256A1 (pl) Nagrzewnica gazu ziemnego
PL390204A1 (pl) Pierścień rozprężny